Skip to content
DraconiticResearch
Search Sources API
194,220 studies31 sourcesUpdated 37 min ago
PreprintCC BYbioRxiv

Diacylglycerol Kinases Balance DAG Signaling to Control B Cell Maturation, Germinal Center Homeostasis, and Humoral Immunity

  1. 1Duke University School of Medicine

Abstract

Diacylglycerol (DAG) is a critical second messenger downstream of the B-cell receptor (BCR), but how DAG signaling is regulated during B-cell development and humoral responses remains incompletely understood. Here, complementary gain- and loss-of-function approaches revealed stage-specific requirements for diacylglycerol kinase (DGK)-regulated signaling in B cells. Expression of the gain-of-function DGK{zeta} mutant DGK{zeta}{Delta}NLS had limited effects on early BM B-cell development but progressively impaired transitional and mature B-cell populations. DGK{zeta}{Delta}NLS attenuated BCR-induced ERK1/2 and mTOR signaling, activation, and proliferation and, when expressed in AID-expressing B cells, reduced GC B-cell survival and T-dependent IgG responses without detectably impairing GC B-cell proliferation in vivo. Conversely, combined DGK/{zeta} deficiency resulted in marked spontaneous GC B-cell expansion associated with enhanced ERK1/2, Akt, and S6 signaling and increased glucose uptake. Despite this steady-state GC expansion, DGK/{zeta}-deficient mice developed spontaneous autoreactivity and mounted impaired antigen-specific antibody responses. Thus, B-cell developmental stages exhibit differential sensitivity to altered DGK activity, and opposing perturbations of DGK-regulated signaling produce reciprocal effects on GC B-cell accumulation while both compromise productive humoral immunity. These findings identify DGKs as critical regulators that tune lipid signaling for B-cell maturation, GC homeostasis, and effective antibody responses.

Related

  1. Context-dependent functions of insulin, IGF, and GLP signaling in inflammatory bowel disease: linking metabolism, immunity, and intestinal homeostasis
    Ezzuddin Abuhussein, Yukihiro Yamaguchi, Dhirendra K. Singh +4
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textGenetics & genomicsCrossref
  2. Cell painting with amphiphile-protein conjugate vaccines drives B cell activation and germinal center priming to enhance humoral immunity
    D. Yadav, E. Templeton, K. Jans +5
    bioRxivPreprintCC BY-NC-NDFull textSystems & synthetic biologybioRxiv
  3. Extracellular redox regulation in Pacific oyster mucosal immunity and microbiota homeostasis
    Fan Mao, Jingchen Song, Xiaoyang Jin +7
    BMC BiologyPeer-reviewedCC BY-NC-ND 4.0ImmunologyCrossref
  4. TRPM2 couples cell-autonomous type-I interferon signaling to pigmentation homeostasis
    Nutan Sharma, Abhishek Tanwar, Changyu Zheng +2
    Journal of Biological ChemistryPeer-reviewedCC BY-NC-ND 4.0Cell biologyCrossref
  5. Listening in Reverse: A Case for Retrograde Signaling During Auditory Inner Hair Cell Ribbon Synapse Maturation.
    Roos A Voorn, Louisa S Kuenkel, Jan F Ahrend +1
    CellsPeer-reviewedCC BYFull textNeuroscienceEurope PMC
BibTeX
@misc{xie2026diacylglycerol,
  title = {{Diacylglycerol Kinases Balance DAG Signaling to Control B Cell Maturation, Germinal Center Homeostasis, and Humoral Immunity}},
  author = {J. Xie and S. Zhang and W. Lee and H. Tao and Y. Pan and X. Luo and X.-P. Zhong},
  howpublished = {bioRxiv},
  year = {2026},
  month = oct,
  doi = {10.64898/2026.10.05.756823},
  url = {https://www.biorxiv.org/content/10.64898/2026.10.05.756823v1},
  note = {CC BY},
}
RIS
TY  - UNPB
TI  - Diacylglycerol Kinases Balance DAG Signaling to Control B Cell Maturation, Germinal Center Homeostasis, and Humoral Immunity
AU  - J. Xie
AU  - S. Zhang
AU  - W. Lee
AU  - H. Tao
AU  - Y. Pan
AU  - X. Luo
AU  - X.-P. Zhong
PY  - 2026
DA  - 2026/10/05
PB  - bioRxiv
DO  - 10.64898/2026.10.05.756823
UR  - https://www.biorxiv.org/content/10.64898/2026.10.05.756823v1
AB  - Diacylglycerol (DAG) is a critical second messenger downstream of the B-cell receptor (BCR), but how DAG signaling is regulated during B-cell development and humoral responses remains incompletely understood. Here, complementary gain- and loss-of-function approaches revealed stage-specific requirements for diacylglycerol kinase (DGK)-regulated signaling in B cells. Expression of the gain-of-function DGK{zeta} mutant DGK{zeta}{Delta}NLS had limited effects on early BM B-cell development but progressively impaired transitional and mature B-cell populations. DGK{zeta}{Delta}NLS attenuated BCR-induced ERK1/2 and mTOR signaling, activation, and proliferation and, when expressed in AID-expressing B cells, reduced GC B-cell survival and T-dependent IgG responses without detectably impairing GC B-cell proliferation in vivo. Conversely, combined DGK/{zeta} deficiency resulted in marked spontaneous GC B-cell expansion associated with enhanced ERK1/2, Akt, and S6 signaling and increased glucose uptake. Despite this steady-state GC expansion, DGK/{zeta}-deficient mice developed spontaneous autoreactivity and mounted impaired antigen-specific antibody responses. Thus, B-cell developmental stages exhibit differential sensitivity to altered DGK activity, and opposing perturbations of DGK-regulated signaling produce reciprocal effects on GC B-cell accumulation while both compromise productive humoral immunity. These findings identify DGKs as critical regulators that tune lipid signaling for B-cell maturation, GC homeostasis, and effective antibody responses.
ER  -